Immune Pharmaceuticals Inc Aktie OTC Bulletin Board
Aktien
IMNP
US45254C1018
IMNP
Pharmazeutika
Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 37 | 12.04.21 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 13.04.21 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11.12.17 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 15.08.17 |
John A. Neczesny
BRD | Director/Board Member | 60 | 02.02.16 |
% 1. Jan. | Kap. | |
---|---|---|
+26.47% | 664 Mrd. | |
+24.65% | 567 Mrd. | |
-6.33% | 354 Mrd. | |
+19.35% | 330 Mrd. | |
+4.23% | 286 Mrd. | |
+14.06% | 234 Mrd. | |
+4.48% | 199 Mrd. | |
-9.94% | 196 Mrd. | |
-4.04% | 148 Mrd. |
- Börse
- Aktien
- A2DQB0 Aktie
- IMNP Aktie